Literature DB >> 19100730

The regulatory mechanisms that underlie inappropriate transcription of the myogenic determination gene Myf5 in the central nervous system.

Philippe Daubas1, Colin G Crist, Lola Bajard, Frédéric Relaix, Emmanuel Pecnard, Didier Rocancourt, Margaret Buckingham.   

Abstract

Myf5 is a key myogenic determination factor, specifically present at sites of myogenesis. Surprisingly, during mouse development, this gene is also transcribed in restricted areas of the central nervous system, although the Myf5 protein is not detectable. We have investigated the regulation of Myf5 expression in the central nervous system. Using both in ovo electroporation in the chick embryo and transgenesis in the mouse, we show that regulatory sequences that direct neuronal Myf5 transcription are present in a distal element located between -55 and -54.3 Kb from the Myf5 gene. An Oct6/Tst1 binding site is required for embryonic brain expression, and in the Oct6 mutant mouse embryo, Myf5 transcripts are no longer detectable in the brain. The Wnt-beta catenin signalling pathway is also implicated. Finally we show that post-transcriptional regulation of Myf5 gene expression involves miRNA repression acting through the Myf5-3'UTR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100730     DOI: 10.1016/j.ydbio.2008.11.031

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  12 in total

1.  Skeletal myogenesis and Myf5 activation.

Authors:  Tanja Francetic; Qiao Li
Journal:  Transcription       Date:  2011-05

2.  Conserved regions of the DMD 3' UTR regulate translation and mRNA abundance in cultured myotubes.

Authors:  C Aaron Larsen; Michael T Howard
Journal:  Neuromuscul Disord       Date:  2014-05-22       Impact factor: 4.296

Review 3.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

4.  eIF2α, a potential target for stem cell-based therapies.

Authors:  Ryo Fujita; Yusuke Ono
Journal:  Stem Cell Investig       Date:  2016-07-22

5.  miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy.

Authors:  Davide Cacchiarelli; Tania Incitti; Julie Martone; Marcella Cesana; Valentina Cazzella; Tiziana Santini; Olga Sthandier; Irene Bozzoni
Journal:  EMBO Rep       Date:  2011-01-07       Impact factor: 8.807

6.  Mechanisms of muscle gene regulation in the electric organ of Sternopygus macrurus.

Authors:  Robert Güth; Matthew Pinch; Graciela A Unguez
Journal:  J Exp Biol       Date:  2013-07-01       Impact factor: 3.312

7.  Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice.

Authors:  Matthew J Harms; Jeff Ishibashi; Wenshan Wang; Hee-Woong Lim; Susumu Goyama; Tomohiko Sato; Mineo Kurokawa; Kyoung-Jae Won; Patrick Seale
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

8.  TF-Cluster: a pipeline for identifying functionally coordinated transcription factors via network decomposition of the shared coexpression connectivity matrix (SCCM).

Authors:  Jeff Nie; Ron Stewart; Hang Zhang; James A Thomson; Fang Ruan; Xiaoqi Cui; Hairong Wei
Journal:  BMC Syst Biol       Date:  2011-04-15

9.  Integration of expressed sequence tag data flanking predicted RNA secondary structures facilitates novel non-coding RNA discovery.

Authors:  Paul M Krzyzanowski; Feodor D Price; Enrique M Muro; Michael A Rudnicki; Miguel A Andrade-Navarro
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

10.  Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments.

Authors:  Ricardo Ribas; Natalia Moncaut; Christine Siligan; Kevin Taylor; Joe W Cross; Peter W J Rigby; Jaime J Carvajal
Journal:  Dev Biol       Date:  2011-04-17       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.